Nanomedicine: Application Areas and Development Prospects

Nanotechnology, along with related concepts such as nanomaterials, nanostructures and nanoparticles, has become a priority area for scientific research and technological development. Nanotechnology, i.e., the creation and utilization of materials and devices at nanometer scale, already has multiple applications in electronics and other fields. However, the greatest expectations are for its application in biotechnology and health, with the direct impact these could have on the quality of health in future societies. The emerging discipline of nanomedicine brings nanotechnology and medicine together in order to develop novel therapies and improve existing treatments. In nanomedicine, atoms and molecules are manipulated to produce nanostructures of the same size as biomolecules for interaction with human cells. This procedure offers a range of new solutions for diagnoses and “smart” treatments by stimulating the body’s own repair mechanisms. It will enhance the early diagnosis and treatment of diseases such as cancer, diabetes, Alzheimer’s, Parkinson’s and cardiovascular diseases. Preventive medicine may then become a reality.

[1]  G. Hughes,et al.  Nanostructure-mediated drug delivery. , 2005, Disease-a-month : DM.

[2]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Ralph Weissleder,et al.  Molecular imaging in the clinical arena. , 2005, JAMA.

[4]  Carlo Montemagno,et al.  Nanotechnology in ophthalmology. , 2010, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[5]  Mauro Ferrari,et al.  Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.

[6]  R. Wooster,et al.  Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. , 2001, Biochemical pharmacology.

[7]  R. Gurny,et al.  Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles. , 2007, International journal of pharmaceutics.

[8]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[9]  Manikandan Jayapal,et al.  DNA MICROARRAY TECHNOLOGY FOR TARGET IDENTIFICATION AND VALIDATION , 2006, Clinical and experimental pharmacology & physiology.

[10]  John Condeelis,et al.  The cofilin pathway in breast cancer invasion and metastasis , 2007, Nature Reviews Cancer.

[11]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[12]  Forrest M Kievit,et al.  Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. , 2011, Advanced drug delivery reviews.

[13]  S. Tamilvanan Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. , 2009, International journal of pharmaceutics.

[14]  Jeong-Woo Choi,et al.  Application of peptide nucleic acid towards development of nanobiosensor arrays. , 2010, Bioelectrochemistry.

[15]  A. Ozcan,et al.  Lensfree holographic imaging of antibody microarrays for high-throughput detection of leukocyte numbers and function. , 2010, Analytical chemistry.

[16]  E. Frenkel,et al.  Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.

[17]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Shao-ling Huang,et al.  Liposomes in ultrasonic drug and gene delivery. , 2008, Advanced drug delivery reviews.

[19]  Doyoung Byun,et al.  A disposable, self-contained PCR chip. , 2009, Lab on a chip.

[20]  Stephen M Hewitt,et al.  Tissue microarrays: bridging the gap between research and the clinic , 2005, Expert review of proteomics.

[21]  V. Mody,et al.  Introduction to metallic nanoparticles , 2010, Journal of pharmacy & bioallied sciences.

[22]  J A Frank,et al.  Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition , 2003, Magnetic resonance in medicine.

[23]  A. Schulze,et al.  Navigating gene expression using microarrays — a technology review , 2001, Nature Cell Biology.

[24]  D. Kraitchman,et al.  Imaging of stem cells using MRI , 2008, Basic Research in Cardiology.

[25]  Á. Delgado,et al.  Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[27]  J. Kang,et al.  Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. , 2003, Cancer genetics and cytogenetics.

[28]  Audrey Player,et al.  Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[29]  R. W. Davis,et al.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[31]  S. Modi,et al.  HER2 breast cancer therapies: a review , 2009, Biologics : targets & therapy.

[32]  H. Tsukada,et al.  T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. , 2010, International journal of pharmaceutics.

[33]  S. Majewski,et al.  Imaging of Mesenchymal Stem Cell Transplant by Bioluminescence and PET , 2007, Journal of Nuclear Medicine.

[34]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[35]  Dipak K. Sarker Engineering of nanoemulsions for drug delivery. , 2005, Current drug delivery.

[36]  David B. Krizman,et al.  The genetics of cancer—a 3D model , 1999, Nature Genetics.

[37]  Ioannis S Vizirianakis,et al.  Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[38]  David G Simpson,et al.  Nanofiber technology: designing the next generation of tissue engineering scaffolds. , 2007, Advanced drug delivery reviews.

[39]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[40]  David G. Morris,et al.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Dobson,et al.  Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery , 2006, Gene Therapy.

[42]  R. E. Oosterbroek,et al.  Lab-on-a-Chip; Miniaturized Systems for (BIO)Chemical Analysis and Synthesis , 2003 .

[43]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[44]  A Surendiran,et al.  Novel applications of nanotechnology in medicine. , 2009, The Indian journal of medical research.

[45]  Mauro Ferrari,et al.  Multi-stage delivery nano-particle systems for therapeutic applications. , 2011, Biochimica et biophysica acta.

[46]  P. Goodfellow,et al.  DNA microarrays in drug discovery and development , 1999, Nature Genetics.

[47]  J. Koda,et al.  Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[48]  D. Gerhold,et al.  Better therapeutics through microarrays , 2002, Nature Genetics.

[49]  Xuetao Cao,et al.  FGF Receptor-mediated Gene Delivery using Ligands Coupled to Polyethylenimine , 2007, Journal of biomaterials applications.

[50]  Andres J Garcia,et al.  Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering. , 2011, Biochimica et biophysica acta.

[51]  S. P. Fodor,et al.  Large-scale genotyping of complex DNA , 2003, Nature Biotechnology.

[52]  Pieter Stroeve,et al.  Synthesis and Characterization of Nanometer-Size Fe3O4 and γ-Fe2O3 Particles , 1996 .

[53]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[54]  O. Salata,et al.  Applications of nanoparticles in biology and medicine , 2004, Journal of nanobiotechnology.

[55]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[56]  R. Stoughton Applications of DNA microarrays in biology. , 2005, Annual review of biochemistry.

[57]  Zonghai Li,et al.  Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. , 2008, International journal of pharmaceutics.

[58]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[59]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[60]  K. Jain,et al.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003, Expert review of molecular diagnostics.

[61]  Satya Prakash,et al.  Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential , 2010, Expert opinion on biological therapy.

[62]  S. Cherry,et al.  PET imaging of transgene expression , 2000, Biological Psychiatry.

[63]  Adalberto Pessoa,et al.  Micellar solubilization of drugs. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[64]  J. Bulte,et al.  In vivo tracking of cellular therapeutics using magnetic resonance imaging. , 2009, Expert opinion on biological therapy.

[65]  Ghaleb A Husseini,et al.  Micelles and nanoparticles for ultrasonic drug and gene delivery. , 2008, Advanced drug delivery reviews.

[66]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Jain Kk,et al.  Nanodiagnostics: application of nanotechnology in molecular diagnostics , 2003, Expert review of molecular diagnostics.

[68]  Kazuo Maruyama,et al.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.

[69]  R. Weissleder Molecular Imaging in Cancer , 2006, Science.

[70]  T Appenzeller,et al.  The man who dared to think small. , 1991, Science.

[71]  Shoji Tajima,et al.  Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. , 2010, Journal of controlled release : official journal of the Controlled Release Society.